Clinical proton MR spectroscopy in central nervous system disorders

G Öz, JR Alger, PB Barker, R Bartha, A Bizzi, C Boesch… - Radiology, 2014 - pubs.rsna.org
A large body of published work shows that proton (hydrogen 1 [1H]) magnetic resonance
(MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality …

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

K Hoang-Xuan, E Bessell, J Bromberg… - The Lancet …, 2015 - thelancet.com
The management of primary CNS lymphoma is one of the most controversial topics in neuro-
oncology because of the complexity of the disease and the very few controlled studies …

Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors

WB Overcast, KM Davis, CY Ho, GD Hutchins… - Current Oncology …, 2021 - Springer
Abstract Purpose of Review This review will explore the latest in advanced imaging
techniques, with a focus on the complementary nature of multiparametric, multimodality …

Imaging biomarker analysis of advanced multiparametric MRI for glioma grading

A Vamvakas, SC Williams, K Theodorou, E Kapsalaki… - Physica Medica, 2019 - Elsevier
Aims and objectives To investigate the value of advanced multiparametric MR imaging
biomarker analysis based on radiomic features and machine learning classification, in the …

[HTML][HTML] Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T

I Tsougos, P Svolos, E Kousi, K Fountas… - Cancer …, 2012 - ncbi.nlm.nih.gov
Purpose: To assess the contribution of 1 H-magnetic resonance spectroscopy (1 H-MRS),
diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI) and dynamic susceptibility …

[HTML][HTML] Magnetic resonance spectroscopy—revisiting the biochemical and molecular milieu of brain tumors

A Verma, I Kumar, N Verma, P Aggarwal, R Ojha - BBA clinical, 2016 - Elsevier
Background Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo
evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction …

MR‐visible lipids and the tumor microenvironment

EJ Delikatny, S Chawla, DJ Leung… - NMR in …, 2011 - Wiley Online Library
MR‐visible lipids or mobile lipids are defined as lipids that are observable using proton MRS
in cells and tissues. These MR‐visible lipids are composed of triglycerides and cholesterol …

Primary central nervous system lymphoma

G Citterio, M Reni, G Gatta, AJM Ferreri - Critical reviews in oncology …, 2017 - Elsevier
Primary CNS lymphomas (PCNSL) represent a subgroup of malignancies with specific
characteristics, aggressive course, and unsatisfactory outcome in contrast with other …

Multimodality assessment of brain tumors and tumor recurrence

WD Heiss, P Raab, H Lanfermann - Journal of Nuclear Medicine, 2011 - Soc Nuclear Med
Neuroimaging plays a significant role in the diagnosis of intracranial tumors, especially brain
gliomas, and must consist of an assessment of location and extent of the tumor and of its …

MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta‐analysis

CH Suh, HS Kim, SC Jung, JE Park… - Journal of Magnetic …, 2019 - Wiley Online Library
Background Accurate preoperative differentiation of primary central nervous system
lymphoma (PCNSL) and glioblastoma is clinically crucial because the treatment strategies …